EUVIMEDEUVIMED entdecken
Crossref

Lebrikizumab for difficult-to-treat atopic dermatitis in a Portuguese cohort

Ana Ferreirinha, Bruno Duarte, Ma. Cristina Fialho, Pedro Simões-Farinha

Portuguese Journal of Dermatology and Venereology · 12.11.2026

DOI: 10.24875/pjdv.26000088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Portuguese Journal of Dermatology and Venereology, online erschienen am 12.11.2026. Verfasst von Ana Ferreirinha und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ferreirinha, A., Duarte, B., Fialho, M. C., & Simões-Farinha, P. (2026). Lebrikizumab for difficult-to-treat atopic dermatitis in a Portuguese cohort. Portuguese Journal of Dermatology and Venereology. https://doi.org/10.24875/pjdv.26000088

Vancouver

Ferreirinha A, Duarte B, Fialho MC, Simões-Farinha P. Lebrikizumab for difficult-to-treat atopic dermatitis in a Portuguese cohort. Portuguese Journal of Dermatology and Venereology. 2026. doi:10.24875/pjdv.26000088

BibTeX
@article{Ferreirinha2026,
  author = {Ferreirinha, Ana and Duarte, Bruno and Fialho, Ma. Cristina and Simões-Farinha, Pedro},
  title = {Lebrikizumab for difficult-to-treat atopic dermatitis in a Portuguese cohort},
  journal = {Portuguese Journal of Dermatology and Venereology},
  year = {2026},
  doi = {10.24875/pjdv.26000088}
}
Kostenlos starten →